EducationPhD University of Oslo (Norway), 1996 (Epidemiology)
MS University of Zagreb (Yugoslavia), 1991 (Biostatistics)
MD University of Zagreb (Yugoslavia), 1987 (Internal Medicine)
Contact Infoemail: email@example.com
4333 Brooklyn Ave NE, Rm 14-315
Seattle, WA 98195-9455
campus box: 359455
Dr. Kopjar is an internationally recognized scholar and expert in biostatistics and clinical epidemiology. As of 2018, he serves as an author/co-author on over 500 published original articles, reviews, technical reports and abstracts. His research interests include: spinal cord injury and diseases, neurosurgery, orthopaedics, preventive medicine and healthcare reform. Dr. Kopjar has been actively participating in the design, management and analysis of clinical trials and medical research for more than 30 years. He is a frequent contributor to peer-reviewed publications such as the Journal of Neurosurgery, the American Journal of Public Health, Spine and the Journal of Bone and Joint Surgery. Dr. Kopjar began his public health career at the Norwegian Foundation for Health Services Research, where he served as its Research Director in the 1990’s. He went on to become the department head of the Section for Preventive Medicine at the Norwegian National Institute of Public Health.
Dr. Kopjar joined the University of Washington in 1997 as a visiting associate professor. Today he is a full-time faculty member and the director of the Executive Master of Public Health (eMPH) program. In addition to his roles at the university, Dr. Kopjar is active in a variety of research organizations including: AOSpine North America, The North American Spine Society (NASS), Cervical Spine Research Society (CSRS) and the International Scholarly Research Network (ISRN). He also serves on the editorial board and as a reviewer for several academic journals. In 2014 Dr. Kopjar was awarded a five-year distinguished professorship to the orthopaedic department at Chongqing University in China. Dr. Kopjar has also held policymaking roles serving as an Advisor to the Minister of Health for two European governments.
Kopjar B, Bohm PE, Arnold JH, Fehlings MG, Tetreault LA, Arnold PM. Outcomes of Surgical Decompression in Patients With Very Severe Degenerative Cervical Myelopathy. Spine (Phila Pa 1976). 2018 Feb 16. doi: 10.1097/BRS.0000000000002602. [Epub ahead of print] PMID: 29462066 PMCID: PMC6066419
Nater A, Tetreault LA, Kopjar B, Arnold PM, Dekutoski MB, Finkelstein JA, Fisher CG, France JC, Gokaslan ZL, Rhines LD, Rose PS, Sahgal A, Schuster JM, Vaccaro AR, Fehlings MG. Predictive factors of survival in a surgical series of metastatic epidural spinal cord compression and complete external validation of 8 multivariate models of survival in a prospective North American multicenter study. Cancer. 2018 Jul 5. doi: 10.1002/cncr.31585. [Epub ahead of print] PMID: 29975401
Harris AI, Luo TD, Lang JE, Kopjar B. Short-term safety and effectiveness of a second-generation motion-guided total knee system. Arthroplast Today. 2018 Feb 16;4(2):240-243. doi: 10.1016/j.artd.2017.11.007. eCollection 2018 Jun. PMID: 29896561 PMCID: PMC5994596
Fehlings MG, Kopjar B, Ibrahim A, Tetreault LA, Arnold PM, Defino H, Kale SS, Yoon ST, Barbagallo GM, Bartels RHM, Zhou Q, Vaccaro AR, Zileli M, Tan G, Yukawa Y, Brodke DS, Shaffrey CI, Santos de Moraes O, Woodard EJ, Scerrati M, Tanaka M, Toyone T, Sasso RC, Janssen ME, Gokaslan ZL, Alvarado M, Bolger C, Bono CM, Dekutoski MB. Geographic variations in clinical presentation and outcomes of decompressive surgery in patients with symptomatic degenerative cervical myelopathy: analysis of a prospective, international multicenter cohort study of 757 patients. Spine J. 2017 Sep 6. pii: S1529-9430(17)30982-8. doi: 10.1016/j.spinee.2017.08.265. [Epub ahead of print] PMID: 28888674
PI: Kopjar Dates: 4/1/2011 - 12/31/2016
The aim of this study is to evaluate efficacy and safety of riluzole in the treatment of patients with acute spinal cord injury (SCI).
Efficacy of Riluzole in Surgical Treatment for Cervical Spondylotic Myelopathy (CSM-Protect)
Study of the efficacy of Riluzole in patients with cervical spondylotic myelopathy undergoing surgical treatment. A randomized, double-blind, placebo-controlled multi-center study